ArticleAmerican journal of hematology2020

C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab.

Carlos de Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.